Havemeyer Place LP Invests $1.73 Million in The Clorox Company $CLX

Posted by Francis Steltz on Jun 7th, 2026

Havemeyer Place LP bought a new position in shares of The Clorox Company (NYSE:CLX – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 17,145 shares of the company’s stock, valued at approximately $1,729,000.

A number of other large investors also recently modified their holdings of the stock. State Street Corp lifted its position in shares of Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares in the last quarter. Invesco Ltd. raised its stake in shares of Clorox by 23.1% during the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after buying an additional 750,415 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after buying an additional 10,060 shares during the last quarter. Van ECK Associates Corp raised its stake in shares of Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after buying an additional 1,312,471 shares during the last quarter. Finally, Two Sigma Investments LP raised its stake in shares of Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Stock Up 4.9%

Shares of NYSE:CLX opened at $94.07 on Friday. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a market capitalization of $11.37 billion, a PE ratio of 15.27, a PEG ratio of 0.49 and a beta of 0.56. The company has a 50 day moving average price of $96.95 and a two-hundred day moving average price of $105.31.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the firm earned $1.45 earnings per share. The business’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price target on shares of Clorox in a research note on Friday, May 1st. Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Finally, Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and an average price target of $103.40.

View Our Latest Analysis on Clorox

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.